<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01476202</url>
  </required_header>
  <id_info>
    <org_study_id>S2111378</org_study_id>
    <nct_id>NCT01476202</nct_id>
  </id_info>
  <brief_title>Provoked Craving Relief Study by NRT</brief_title>
  <acronym>NRT</acronym>
  <official_title>A Pilot Study to Evaluate Relief of Provoked Acute Craving by Nicotine Mouth Strip, Nicorette Â® Nicotine Lozenge and Gum</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>GlaxoSmithKline</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>GlaxoSmithKline</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to assess the ability of the mint nicotine mouth strip to relieve
      provoked cigarette craving in light smokers compared to nicotine lozenge and nicotine gum.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2011</start_date>
  <completion_date type="Actual">January 2012</completion_date>
  <primary_completion_date type="Actual">January 2012</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean Change From Baseline in Nicotine Craving Score on a VAS</measure>
    <time_frame>Baseline, 50 seconds, 3, 5, 7, 10, 15, 20, 25 and 30 minutes post treatment administration</time_frame>
    <description>Participants completed a nicotine craving assessment consisting of following five items: I have a desire for a cigarette right now, if it were possible I would smoke right now, All I want right now is a cigarette, I have an urge for a cigarette, I crave a cigarette right now. All participants indicated their craving intensity on a pre-drawn 100 mm scale ranging from 0 (disagree) to 100 (agree). At the end of the craving assessment period, mean VAS score was measured.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Log Transformed Area Under the Curve of Nicotine Craving Score (AUC)</measure>
    <time_frame>Baseline, 50 seconds, 3, 5, 7, 10, 15, 20, 25, and 30 minutes post treatment administration</time_frame>
    <description>AUC between the baseline (pre-dose) and the time of measurement of craving on-treatment was determined.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Smoking Cessation</condition>
  <arm_group>
    <arm_group_label>Nicotine mouth strip</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>single dose</description>
  </arm_group>
  <arm_group>
    <arm_group_label>nicotine lozenge</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>single dose</description>
  </arm_group>
  <arm_group>
    <arm_group_label>nicotine gum</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>single dose</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>nicotine</intervention_name>
    <description>nicotine in the form of a mouth strip, lozenge and gum</description>
    <arm_group_label>nicotine gum</arm_group_label>
    <arm_group_label>nicotine lozenge</arm_group_label>
    <arm_group_label>Nicotine mouth strip</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Smoking Status: Current cigarette smokers who have smoked regularly for at least a
             year and smoke their first cigarette more than 30 minutes after waking up.

        Exclusion Criteria:

          -  Allergy/Intolerance: Known or suspected intolerance or hypersensitivity to nicotine
             (or closely related compounds) or any of the stated ingredients in formulation.

          -  Prior Concomitant Medication: a. Treatment with known enzyme altering agents (e.g.
             carbamazepine, phenytoin, cimetidine, sodium valporate) within 30 days of the craving
             provocation visit. b. Use of any prescription psychoactive medication (such as but not
             limited to antidepressants, antipsychotics, anxiolytics) within 14 days of the craving
             provocation visit. c. Use of any over-the-counter (OTC) medication that affects
             central nervous system such as antihistamines, sedating agents, or any compound that
             would have a sedating effect within 24 hours of the craving provocation visit. d. Use
             of any nicotine replacement therapy or any other treatment for smoking cessation (e.g.
             bupropion or varenicline) within one month of screening visit. e. Use of any nicotine
             containing products at any time during the Provocation/Treatment visit. f. Use of any
             medications noted in the exclusion criteria, or use of any product that would, in the
             opinion of the investigator, jeopardize the safety of the subject or impact on the
             validity of the study results.

          -  Any disease that, in the opinion of the investigator, may interfere with the
             absorption, metabolism or excretion of the study product. A medical history that, in
             the opinion of the investigator, might jeopardise the safety of the subject or the
             validity of the study results. For example, recent myocardial infarction or
             cerebrovascular accident (within 12 weeks of the screening visit), phenylketonuria,
             unstable or worsening angina pectoris, Prinzmetals angina or severe cardiac
             arrhythmia.

          -  Expired Carbon Monoxide (CO): Any subject whose CO level rises during the
             sequestration period (i.e., the subject's expired CO assessments immediately prior to
             the provoked craving paradigm are higher than the mean baseline CO assessment) and, in
             the opinion of the investigator, may have smoked during that time.

          -  Alcohol: Consumption of any alcoholic beverage within 24 hours of the craving
             provocation visit, as indicated by a positive breath alcohol test.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>GSK Clinical Trials</last_name>
    <role>Study Director</role>
    <affiliation>GlaxoSmithKline</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Central Kentucky Research Associates, Inc.</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40509</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 17, 2011</study_first_submitted>
  <study_first_submitted_qc>November 17, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 22, 2011</study_first_posted>
  <results_first_submitted>July 30, 2013</results_first_submitted>
  <results_first_submitted_qc>July 30, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">September 30, 2013</results_first_posted>
  <last_update_submitted>July 30, 2013</last_update_submitted>
  <last_update_submitted_qc>July 30, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 30, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>craving, provoked craving, smoking cessation, nicotine replacement therapy, NRT</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nicotine</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Participants were recruited at the clinical site.</recruitment_details>
      <pre_assignment_details>Of 140 screened participants, 120 were randomized while 17 participants were screen failures, and 3 participants were not randomized due to other reasons.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Nicotine Mouth Strip 2.5 Milligram (mg)</title>
          <description>Participants self administered a single dose of 2.5 mg nicotine mouth strip.</description>
        </group>
        <group group_id="P2">
          <title>Nicotine Lozenge 2 mg</title>
          <description>Participants self administered a single dose of 2 mg nicotine lozenge.</description>
        </group>
        <group group_id="P3">
          <title>Nicotine Gum 2 mg</title>
          <description>Participants self administered a single dose of 2 mg nicotine gum.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="40"/>
                <participants group_id="P2" count="40"/>
                <participants group_id="P3" count="40"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="40"/>
                <participants group_id="P2" count="40"/>
                <participants group_id="P3" count="40"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Nicotine Mouth Strip 2.5 mg</title>
          <description>Participants self administered a single dose of 2.5 mg nicotine mouth strip.</description>
        </group>
        <group group_id="B2">
          <title>Nicotine Lozenge 2 mg</title>
          <description>Participants self administered a single dose of 2 mg nicotine lozenge.</description>
        </group>
        <group group_id="B3">
          <title>Nicotine Gum 2 mg</title>
          <description>Participants self administered a single dose of 2 mg nicotine lozenge.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="40"/>
            <count group_id="B2" value="40"/>
            <count group_id="B3" value="40"/>
            <count group_id="B4" value="120"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="35.5" spread="11.4"/>
                    <measurement group_id="B2" value="34.8" spread="10.9"/>
                    <measurement group_id="B3" value="37.4" spread="11.5"/>
                    <measurement group_id="B4" value="35.0" spread="11.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="27"/>
                    <measurement group_id="B4" value="72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="13"/>
                    <measurement group_id="B4" value="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Mean Change From Baseline in Nicotine Craving Score on a VAS</title>
        <description>Participants completed a nicotine craving assessment consisting of following five items: I have a desire for a cigarette right now, if it were possible I would smoke right now, All I want right now is a cigarette, I have an urge for a cigarette, I crave a cigarette right now. All participants indicated their craving intensity on a pre-drawn 100 mm scale ranging from 0 (disagree) to 100 (agree). At the end of the craving assessment period, mean VAS score was measured.</description>
        <time_frame>Baseline, 50 seconds, 3, 5, 7, 10, 15, 20, 25 and 30 minutes post treatment administration</time_frame>
        <population>Intent to Treat (ITT) Population: All randomized participants who had at least one dose of medication and provided at least one craving assessment measurement on treatment. The imputation of missing craving score was based on last observation carried forward (LOCF) technique.</population>
        <group_list>
          <group group_id="O1">
            <title>Nicotine Mouth Strip 2.5 mg</title>
            <description>Participants self administered a single dose of 2.5 mg nicotine mouth strip.</description>
          </group>
          <group group_id="O2">
            <title>Nicotine Lozenge 2 mg</title>
            <description>Participants self administered a single dose of 2 mg nicotine lozenge.</description>
          </group>
          <group group_id="O3">
            <title>Nicotine Gum 2 mg</title>
            <description>Participants self administered a single dose of 2 mg nicotine gum.</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Change From Baseline in Nicotine Craving Score on a VAS</title>
          <description>Participants completed a nicotine craving assessment consisting of following five items: I have a desire for a cigarette right now, if it were possible I would smoke right now, All I want right now is a cigarette, I have an urge for a cigarette, I crave a cigarette right now. All participants indicated their craving intensity on a pre-drawn 100 mm scale ranging from 0 (disagree) to 100 (agree). At the end of the craving assessment period, mean VAS score was measured.</description>
          <population>Intent to Treat (ITT) Population: All randomized participants who had at least one dose of medication and provided at least one craving assessment measurement on treatment. The imputation of missing craving score was based on last observation carried forward (LOCF) technique.</population>
          <units>Score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="40"/>
                <count group_id="O3" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>50 seconds</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-11.3" spread="17.2"/>
                    <measurement group_id="O2" value="-1.7" spread="6.0"/>
                    <measurement group_id="O3" value="-4.6" spread="9.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-28.2" spread="28.8"/>
                    <measurement group_id="O2" value="-12.0" spread="20.7"/>
                    <measurement group_id="O3" value="-17.6" spread="18.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-35.8" spread="31.0"/>
                    <measurement group_id="O2" value="-18.3" spread="22.8"/>
                    <measurement group_id="O3" value="-27.2" spread="24.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>7 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-39.0" spread="33.2"/>
                    <measurement group_id="O2" value="-25.5" spread="27.2"/>
                    <measurement group_id="O3" value="-33.8" spread="27.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>10 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-43.9" spread="31.8"/>
                    <measurement group_id="O2" value="-30.0" spread="26.0"/>
                    <measurement group_id="O3" value="-38.4" spread="29.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>15 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-45.2" spread="33.3"/>
                    <measurement group_id="O2" value="-34.4" spread="29.1"/>
                    <measurement group_id="O3" value="-40.2" spread="30.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>20 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-47.9" spread="30.0"/>
                    <measurement group_id="O2" value="-37.4" spread="30.1"/>
                    <measurement group_id="O3" value="-42.7" spread="31.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>25 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-47.3" spread="33.8"/>
                    <measurement group_id="O2" value="-40.7" spread="30.9"/>
                    <measurement group_id="O3" value="-43.5" spread="29.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-45.2" spread="35.3"/>
                    <measurement group_id="O2" value="-42.8" spread="32.1"/>
                    <measurement group_id="O3" value="-42.3" spread="31.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Log Transformed Area Under the Curve of Nicotine Craving Score (AUC)</title>
        <description>AUC between the baseline (pre-dose) and the time of measurement of craving on-treatment was determined.</description>
        <time_frame>Baseline, 50 seconds, 3, 5, 7, 10, 15, 20, 25, and 30 minutes post treatment administration</time_frame>
        <population>Intent to Treat (ITT) Population: All randomized participants who had at least one dose of medication and provided at least one craving assessment measurement on treatment. The imputation of missing craving score was based on LOCF technique.</population>
        <group_list>
          <group group_id="O1">
            <title>Nicotine Mouth Strip 2.5 Milligram (mg)</title>
            <description>Participants self administered single dose of 2.5 mg nicotine mouth strip.</description>
          </group>
          <group group_id="O2">
            <title>Nicotine Lozenge 2 mg</title>
            <description>Participants self administered single dose of 2 mg nicotine lozenge.</description>
          </group>
          <group group_id="O3">
            <title>Nicotine Gum 2 mg</title>
            <description>Participants self administered single dose of 2 mg nicotine gum.</description>
          </group>
        </group_list>
        <measure>
          <title>Log Transformed Area Under the Curve of Nicotine Craving Score (AUC)</title>
          <description>AUC between the baseline (pre-dose) and the time of measurement of craving on-treatment was determined.</description>
          <population>Intent to Treat (ITT) Population: All randomized participants who had at least one dose of medication and provided at least one craving assessment measurement on treatment. The imputation of missing craving score was based on LOCF technique.</population>
          <units>Score on a scale*minutes</units>
          <param>Log Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="40"/>
                <count group_id="O3" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>AUC (0-50 seconds)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.0" lower_limit="3.99" upper_limit="4.05"/>
                    <measurement group_id="O2" value="4.1" lower_limit="4.05" upper_limit="4.12"/>
                    <measurement group_id="O3" value="4.1" lower_limit="4.03" upper_limit="4.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AUC (0-3 minutes)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.1" lower_limit="5.06" upper_limit="5.20"/>
                    <measurement group_id="O2" value="5.3" lower_limit="5.23" upper_limit="5.38"/>
                    <measurement group_id="O3" value="5.2" lower_limit="5.17" upper_limit="5.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AUC (0-5 minutes)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.5" lower_limit="5.42" upper_limit="5.61"/>
                    <measurement group_id="O2" value="5.7" lower_limit="5.65" upper_limit="5.84"/>
                    <measurement group_id="O3" value="5.7" lower_limit="5.57" upper_limit="5.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AUC (0-7 minutes)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.8" lower_limit="5.64" upper_limit="5.87"/>
                    <measurement group_id="O2" value="6.0" lower_limit="5.89" upper_limit="6.12"/>
                    <measurement group_id="O3" value="5.9" lower_limit="5.81" upper_limit="6.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AUC (0-10 minutes)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.0" lower_limit="5.88" upper_limit="6.14"/>
                    <measurement group_id="O2" value="6.3" lower_limit="6.14" upper_limit="6.41"/>
                    <measurement group_id="O3" value="6.2" lower_limit="6.05" upper_limit="6.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AUC (0-15 minutes)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.3" lower_limit="6.15" upper_limit="6.45"/>
                    <measurement group_id="O2" value="6.6" lower_limit="6.42" upper_limit="6.73"/>
                    <measurement group_id="O3" value="6.5" lower_limit="6.32" upper_limit="6.62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AUC (0-20 minutes)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.5" lower_limit="6.35" upper_limit="6.68"/>
                    <measurement group_id="O2" value="6.8" lower_limit="6.62" upper_limit="6.95"/>
                    <measurement group_id="O3" value="6.7" lower_limit="6.50" upper_limit="6.83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AUC (0-25 minutes)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.7" lower_limit="6.51" upper_limit="6.87"/>
                    <measurement group_id="O2" value="6.9" lower_limit="6.76" upper_limit="7.12"/>
                    <measurement group_id="O3" value="6.8" lower_limit="6.64" upper_limit="7.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AUC (0-30 minutes)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.8" lower_limit="6.65" upper_limit="7.03"/>
                    <measurement group_id="O2" value="7.1" lower_limit="6.87" upper_limit="7.25"/>
                    <measurement group_id="O3" value="7.0" lower_limit="6.76" upper_limit="7.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>AEs were collected from the start of the smoking abstinence sequestration period and until 5 days following last administration of the investigational product.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Nicotine Mouth Strip 2.5 mg</title>
          <description>Participants self administered single dose of 2.5 mg nicotine mouth strip.</description>
        </group>
        <group group_id="E2">
          <title>Nicotine Lozenge 2 mg</title>
          <description>Participants self administered single dose of 2 mg nicotine lozenge.</description>
        </group>
        <group group_id="E3">
          <title>Nicotine Gum 2 mg</title>
          <description>Participants self administered single dose of 2 mg nicotine gum.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>1</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="40"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Nausae</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="40"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Hiccups</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Throat Irritation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>GSK Response Center</name_or_title>
      <organization>GlaxoSmithKline</organization>
      <phone>866-435-7343</phone>
    </point_of_contact>
  </clinical_results>
</clinical_study>

